Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L R Lard

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical and Experimental Rheumatology|August 11, 2004
Comparison of the baseline disease activity of early oligo- and polyarthritis in sequential yearsL M A Jansen, I E van der Horst-Bruinsma, D van Schaardenburg, et al.
Scandinavian Journal of Rheumatology|July 15, 2021
Comparison between 1.5T and 3.0T MRI: both field strengths sensitively detect subclinical inflammation of hand and forefoot in patients with arthralgiaD I Krijbolder, M Verstappen, F Wouters, et al.
Seminars in Arthritis and Rheumatism|May 14, 2025
A comparison of short-term efficacy and toxicity of 2 glucocorticoid bridging strategies in 2 clinical trials in early rheumatoid and undifferentiated arthritisJ A van der Pol, E G Brilman, P H P de Jong, et al.
American Journal of Hematology|January 5, 2002
Low adjusted-dose acenocoumarol therapy in sickle cell disease: a pilot studyJ B Schnog, A P Kater, M R Mac Gillavry, et al.
Annals of the Rheumatic Diseases|August 19, 2003
Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritisM Boers, M T Nurmohamed, C J A Doelman, et al.
Arthritis and Rheumatism|July 9, 2003
Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritisL R Lard, F A van Gaalen, J J M Schonkeren, et al.
Arthritis and Rheumatism|April 16, 2002
Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damageL R Lard, M Boers, A Verhoeven, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical and Experimental Rheumatology|August 11, 2004
Comparison of the baseline disease activity of early oligo- and polyarthritis in sequential yearsL M A Jansen, I E van der Horst-Bruinsma, D van Schaardenburg, et al.
Scandinavian Journal of Rheumatology|July 15, 2021
Comparison between 1.5T and 3.0T MRI: both field strengths sensitively detect subclinical inflammation of hand and forefoot in patients with arthralgiaD I Krijbolder, M Verstappen, F Wouters, et al.
Seminars in Arthritis and Rheumatism|May 14, 2025
A comparison of short-term efficacy and toxicity of 2 glucocorticoid bridging strategies in 2 clinical trials in early rheumatoid and undifferentiated arthritisJ A van der Pol, E G Brilman, P H P de Jong, et al.
American Journal of Hematology|January 5, 2002
Low adjusted-dose acenocoumarol therapy in sickle cell disease: a pilot studyJ B Schnog, A P Kater, M R Mac Gillavry, et al.
Annals of the Rheumatic Diseases|August 19, 2003
Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritisM Boers, M T Nurmohamed, C J A Doelman, et al.
Arthritis and Rheumatism|July 9, 2003
Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritisL R Lard, F A van Gaalen, J J M Schonkeren, et al.
Arthritis and Rheumatism|April 16, 2002
Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damageL R Lard, M Boers, A Verhoeven, et al.
Pageof 2